ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 276361 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 276361; 2) Community: the network communities that were significantly associated with the response to NSC 276361; 3) Molecule: the relationships between components within communities and NSC 276361; 4) MDR: the compounds that were significantly associated with the NSC 276361.

NSC Compound Enrichment Correlation
NSC 713018 Null 0.024108502230778 -0.13029789
NSC 726768 5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline 0.024108502230778 0.35371067
NSC 94600 Camptothecin 0.024108502230778 0.38737136
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0241085022307781 0.43195271
NSC 169774 Bromocriptine methanesulfonate 0.0241085022307781 0.03361558
NSC 650269 Null 0.0247979034812107 -0.062574
NSC 740345 3-3'-(1H-pyrazole-3,5-diyl)bis(1-methyl-1H-indole) 0.0247979034812107 0.16294399
NSC 23925 Null 0.0247979034812109 0.13007529
NSC 641245 Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- 0.024797903481211 -0.13538359
NSC 656243 Benzo[1,2-b:5,4-b']dithiophene-2-carboxylic acid, 4,8-dioxo- 0.024797903481211 -0.2555097
Total:44  Current:21    [First] [Prev] [Next] [Last]